Phenome-Wide Risk Evaluation of GLP-1 Receptor Agonist Use in Type 2 Diabetes with Real-World Data Across Multiple Healthcare Systems.

Saved in:
Bibliographic Details
Title: Phenome-Wide Risk Evaluation of GLP-1 Receptor Agonist Use in Type 2 Diabetes with Real-World Data Across Multiple Healthcare Systems.
Authors: Vashisht R; Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, USA., Dhruva SS; Section of Cardiology, Department of Medicine, School of Medicine, University of California, San Francisco, San Francisco, CA, USA.; San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA., Patel A; Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, USA.; Center for Data-driven Insights and Innovation, University of California Health, Oakland., Dahm L; Center for Data-driven Insights and Innovation, University of California Health, Oakland., Morris P; Center for Data-driven Insights and Innovation, University of California Health, Oakland., Gonzalez D; Center for Data-driven Insights and Innovation, University of California Health, Oakland., Follett R; Center for Data-driven Insights and Innovation, University of California Health, Oakland., Sirota M; Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, USA., Singh K; Digital Health Innovation, University of California San Diego Health, San Diego., Han C; Center for Data-driven Insights and Innovation, University of California Health, Oakland., Koliwad S; Division of Endocrinology and Metabolism, University of California-San Francisco, San Francisco, CA, USA., Butte AJ; Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, USA.; Center for Data-driven Insights and Innovation, University of California Health, Oakland.
Source: MedRxiv : the preprint server for health sciences [medRxiv] 2025 Aug 15. Date of Electronic Publication: 2025 Aug 15.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
DOI:10.1101/2025.08.13.25333579